+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of acute lung injury and fibrosis with antagonists of beta6-specific antibodies

Treatment of acute lung injury and fibrosis with antagonists of beta6-specific antibodies

Official Gazette of the United States Patent & Trademark Office Patents 1279(3), Feb 17

Methods and compositions comprising antagonists of alphavbeta6 are provided for the treatment of acute lung injury fibrosis.

(PDF emailed within 1 workday: $29.90)

Accession: 035980787

Download citation: RISBibTeXText

Related references

Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. British Journal of Haematology 93(3): 707-713, 1996

Role of integrin alphav beta6 in acute lung injury induced by Pseudomonas aeruginosa. Infection and Immunity 76(6): 2325-2332, 2008

Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. Journal of Clinical Investigation 116(6): 1606-1614, 2006

Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice. Experimental Lung Research 38(1): 28-36, 2012

Antibodies specific for beta6 integrins. Official Gazette of the United States Patent & Trademark Office Patents 1252(2), Nov 13, 2001

Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. Journal of Heart and Lung Transplantation 32(1): 70-77, 2013

Acute lung injury/acute respiratory distress syndrome: progress in diagnosis and treatment topics: IV. Recent topics; 2. Long-term prognosis of acute lung injury. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(6): 1607-1612, 2011

Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 283(5): L1023-L1032, 2002

Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury. Journal of Surgical Research 185(2): 740-747, 2014

Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis. Anatomical Record 292(4): 580-586, 2009

Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice. American Journal of Respiratory Cell and Molecular Biology 19(4): 636-642, 1998

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine 177(1): 82-90, 2007

Case report: four donors with granulocyte-specific or HLA class I antibodies implicated in a case of transfusion-related acute lung injury (TRALI). Immunohematology 17(4): 117-121, 2004

Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S61-S72, 2016